Article on clinical trials of KRN23

Last year, our Scientific Advisory Board member, Dr. Carpenter, won the "Most Outstanding Clinical Abstract Award" at the annual conference of the American Society of Bone and Mineral Research.

Now you can read the full article about the clinical trials of KRN23, by Dr. Carpenter and other outstanding researchers, as published in the Journal of Clinical Investigation. It's entitled, "Randomized Trials of the anti-FGF23 antibody KRN23 in X-Linked Hypophosphatemia," and is online here.